Backed by science.
Our programs are evidence-based, with studies published in peer-reviewed journals.
In 2014, the Gibson Institute of Cognitive Research was established to conduct empirical research on cognitive training programs and assessments. Findings are published and presented in peer-reviewed journals and conferences for the education, psychology, neuroscience and cognitive science communities.
LearningRx Findings
Transfer effects and quantitative results from randomised control trials, controlled studies, quasi-experimental studies and pilot trials are documented in the "Research Results and Learning Outcomes".
Children & Teens
with ADHD
improved confidence, cooperative behaviors, and self-discipline
with Learning Struggles
improved academic skills, self-esteem, relationships, and self-discipline
At Risk High Schoolers
improved attitudes about math
School-agers
less academic difficulty & oppositional behavior
Gains among school-agers
working memory, logic & reasoning, processing speed, auditory processing, Word Attack
Adults
50's to Seniors
improvements in mood, work performance, driving, hobbies and sports, problem-solving, anxiety, confidence, hope, outlook, memory, and focus
Adults with Brain Injury
increased confidence and perseverance, improved attention, memory, affect, motivation, work performance, and outlook on life, gains in working memory, IQ score, auditory processing, long-term memory, auditory working memory, and logic & reasoning
Seniors with Mild Cognitive Impairment
improved social interactions, marital relationships, restoration of hope, confidence to return to school and work, and decreased depression
LearningRx Research
Moore, A.L., & Ledbetter, C. (2019). The Promise of Clinician-Delivered Cognitive Training for Children Diagnosed with ADHD. Journal of Mental Health and Clinical Psychology, 3(3), 3-8. doi: 10.29245/2578-2959/2019/3.1180
​
Moore, A.L., Carpenter, D.M., Ledbetter, C., & Miller, T.M. (2018). Clinician-delivered cognitive training for children with attention problems: Transfer effects on cognitive and behavior from the ThinkRx randomized controlled trial. Neuropsychiatric Disease and Treatment, 14, 1671-1683. doi: 10.2147/NDT.S165418